Literature DB >> 10224087

Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway.

J L Todd1, K G Tanner, J M Denu.   

Abstract

The mammalian dual-specificity protein-tyrosine phosphatase VHR (for VH1-related) has been identified as a novel regulator of extracellular regulated kinases (ERKs). To identify potential cellular substrates of VHR, covalently immobilized mutant VHR protein was employed as an affinity trap. A tyrosine-phosphorylated protein(s) of approximately 42 kDa was specifically adsorbed by the affinity column and identified as ERK1 and ERK2. Subsequent kinetic analyses and transfection studies demonstrated that VHR specifically dephosphorylates and inactivates ERK1 and ERK2 in vitro and in vivo. Only the native structure of phosphorylated ERK was recognized by VHR and was inactivated with a second-order rate constant of 40,000 M-1 s-1. VHR was found to dephosphorylate endogenous ERK, but not p38 and JNK. Immunodepletion of endogenous VHR eliminated the dephosphorylation of cellular ERK. Transfection studies in COS-1 cells demonstrated that in vivo phosphorylation of epidermal growth factor-stimulated ERK depended on VHR protein levels. Overexpression above endogenous levels of VHR led to accelerated ERK inactivation, but did not alter the normal activation of ERK. Unique among reported mitogen activated protein kinase phosphatases, VHR is constitutively expressed, localized to the nucleus, and tyrosine-specific. This study is the first to report the identification of authentic substrates of dual-specificity phosphatases utilizing affinity absorbents and is the first to identify a nuclear, constitutively expressed, and tyrosine-specific ERK phosphatase. The data strongly suggest that VHR is responsible for the rapid inactivation of ERK following stimulation and for its repression in quiescent cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10224087     DOI: 10.1074/jbc.274.19.13271

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Distinct, constitutively active MAPK phosphatases function in Xenopus oocytes: implications for p42 MAPK regulation In vivo.

Authors:  M L Sohaskey; J E Ferrell
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

2.  Diffusion control of protein phosphorylation in signal transduction pathways.

Authors:  B N Kholodenko; G C Brown; J B Hoek
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

Review 3.  Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets.

Authors:  D W Hommes; M P Peppelenbosch; S J H van Deventer
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

4.  Characterization of a novel low-molecular-mass dual specificity phosphatase-4 (LDP-4) expressed in brain.

Authors:  Kentaro Takagaki; Hiroshi Shima; Nobuhiro Tanuma; Miyuki Nomura; Takeshi Satoh; Masahiko Watanabe; Kunimi Kikuchi
Journal:  Mol Cell Biochem       Date:  2006-09-26       Impact factor: 3.396

5.  KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.

Authors:  Klaus W Wagner; Hunain Alam; Shilpa S Dhar; Uma Giri; Na Li; Yongkun Wei; Dipak Giri; Tina Cascone; Jae-Hwan Kim; Yuanqing Ye; Asha S Multani; Chia-Hsin Chan; Baruch Erez; Babita Saigal; Jimyung Chung; Hui-Kuan Lin; Xifeng Wu; Mien-Chie Hung; John V Heymach; Min Gyu Lee
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

Review 6.  Protein tyrosine phosphatases--from housekeeping enzymes to master regulators of signal transduction.

Authors:  Nicholas K Tonks
Journal:  FEBS J       Date:  2013-01-17       Impact factor: 5.542

7.  Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation.

Authors:  P Najarro; P Traktman; J A Lewis
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

8.  Proofreading through spatial gradients.

Authors:  Vahe Galstyan; Kabir Husain; Fangzhou Xiao; Arvind Murugan; Rob Phillips
Journal:  Elife       Date:  2020-12-24       Impact factor: 8.140

9.  Specificity profiling of dual specificity phosphatase vaccinia VH1-related (VHR) reveals two distinct substrate binding modes.

Authors:  Rinrada Luechapanichkul; Xianwen Chen; Hashem A Taha; Shubham Vyas; Xiaoyan Guan; Michael A Freitas; Christopher M Hadad; Dehua Pei
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

10.  Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells.

Authors:  Shuangding Wu; Sofie Vossius; Souad Rahmouni; Ana V Miletic; Torkel Vang; Jesus Vazquez-Rodriguez; Fabio Cerignoli; Yutaka Arimura; Scott Williams; Tikva Hayes; Michel Moutschen; Stefan Vasile; Maurizio Pellecchia; Tomas Mustelin; Lutz Tautz
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.